Unilever made an offer of around £50 billion (about €60 billion) at the end of last year to acquire the consumer division of GlaxoSmithKline (GSK), the British newspaper reports. The Sunday Times Saturday based on insiders. However, that offer was rejected by the board of GSK and that of shareholder Pfizer, who found it too low.
ttn-19
